THE SAGE GROUP Estimates the Economic Cost of Critical Limb Ischemia Amputations at $25 Billion. August 15, 2014

THE SAGE GROUP LLC Announces Publication of an Article Titled “Cost-Benefit Analysis of Amputation in the Era of the Affordable Care Act. Is it Fiscally Responsible to Perform Primary Amputation as Treatment?” in the May Issue of Endovascular Today. June 2, 2014

In Recognition of National Diabetes Month, THE SAGE GROUP LLC Highlights the Interrelationships Between Peripheral Artery Disease (PAD) and Diabetes, Diabetic Foot Ulcers (DFU) and Amputation. November 12, 2013

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Disease. September 5, 2013

According to THE SAGE GROUP Peripheral Artery Disease Amputations are Costly for the Economy, the Hospital and for the Patient. August 19, 2013

THE SAGE GROUP Reports that Approximately 14 Million People in South America Suffer from Peripheral Artery Disease. July 9, 2013

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Socioeconomics of Amputation at the Save A Leg Save A Life Foundation Annual National Conference. April 8, 2013

THE SAGE GROUP LLC Announces that Mary L. Yost, President, is a Featured Panelist in the Medscape Program Titled “The Price of PAD: The Clinical and Economic Consequences of Amputation.” September 17, 2012

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on Current Knowledge and Treatment of the Disease. September 10, 2012

THE SAGE GROUP LLC Celebrates its Tenth Anniversary as the Leading Research and Consulting Company Specializing in Peripheral Artery Disease and Critical Limb Ischemia. May 16, 2012

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Peripheral Artery Disease (PAD) Prevalence and Economics at the NEW CARDIOVASCULAR HORIZONS Conference. May 2, 2012

THE SAGE GROUP Announces Publication of Peripheral Artery Disease Coding and Reimbursement Featuring an Overview of the Upcoming ICD-10 Diagnosis and Procedure Codes. February 27, 2012

According to THE SAGE GROUP the Total Annual Economic Burden of Peripheral Artery Disease (PAD) in the U.S. Exceeds $300 Billion. November 14, 2011

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Economic Burden of the Disease. September 8, 2011

THE SAGE GROUP Estimates That the 2010 Annual Economic Cost of Peripheral Artery Disease (PAD) Was $164 to $290 Billion. June 1, 2011